When embryonic stem cells are differentiated in the presence of activin A in serum-free conditions, an endoderm progenitor population defined by the coexpression of either Brachyury, Foxa2 and c-Kit, or c-Kit and Cxcr4 is generated. Specification of these progenitors with bone morphogenetic protein-4 in combination with basic fibroblast growth factor and activin A results in the development of hepatic populations highly enriched (45-70%) for cells that express the alpha-fetoprotein and albumin proteins.
HSBK003-15
stemcellbook June 11, 2012 12:16 Monolayer endoderm differentiation from human ESCs spin down @ 1200 rpm for 3 min. Resuspend cells in T5 media and seed onto 1:6 matrigel-coated 6-well plate @ 250K cells/well. 5. Feed cells every two days with different differentiation media (recipe below) and harvest between 18-25 days for analysis. Prepare a stock solution of 5 mg/mL in cold TC-H 2 O. Leave on ice and vortex periodically until completely dissolved. Filter sterilize, aliquot and store at −20 • C. Use once and discard.
Reagents and preparation

MONOTHIOGLYCEROL (MTG) (SIGMA# M-6145)
The amounts of MTG indicated in our protocols are recommended concentrations. However, it is important to test each new batch of MTG as there is variability between them. MTG should be aliquoted (1 mL) and stored frozen (−20 • C). When aliquots are thawed, they can be used for several experiments and then discarded. Aliquoting of MTG is strongly recommended as it minimizes the amount of oxidation due to repeated opening. HSBK003-15 stemcellbook June 11, 2012 12:16 Monolayer endoderm differentiation from human ESCs * MATRIGEL (REDUCED FACTOR) (BD# 354230) Each batch of matrigel has its own unique levels of endotoxin and protein concentrations. We find that the endotoxin levels should not be higher than 2 endotoxin units/mL and the protein levels should range between 7 to 10 mg/mL. If the protein levels are higher than this you may need to dilute the matrigel more than 1:1. This is determined by observing the hESC colony morphology and the ability of the hESCs to differentiate into the lineage required of them.
Caution: When working with matrigel, all tubes, plates and pipettes should be pre-chilled, as matrigel solidifies at room temperature.
MATRIGEL1:1 PREPARATION
1. Thaw frozen bottles of matrigel on ice overnight in the cold room. We normally thaw 6×5-mL bottles per batch. 2. The next day, make a 50% working stock by adding an equal volume of IMDM+P/S to each bottle. Resuspend gently with a pre-chilled 5 mL pipette. 3. Leave the bottles on ice all day to allow the matrigel to completely equilibrate with IMDM. 4. Pool 3 bottles of 1:1 matrigel (30 mL) into a pre-chilled 50 mL tube. Gently mix with a chilled 10 mL pipette and aliquot. 5. Transfer 2.5 mL into pre-chilled and pre-labelled 4-mL snap cap tubes 6. Store aliquots at −20
• C hES Media (500 ml) DMEM/F12: 400 ml KOSR: 100 ml NEAA: 5 ml L-glutamine: 5 ml Pen/strep: 5 ml ␤-Mercaptoethanol: 3.5 ul bFGF: 10 ng/ml (50 ul of 100 ug/ml stock) L-Ascorbic Acid: 50 ug/ml -add fresh 5 mg/ml stock at each media change Detailed differentiation media:
T0 Media Basic Media RPMI Ingredient Stock Volume Final Glutamine 100x 10 ul/ml 1x MTG 13 ul/ml 3 ul/ml 4.5 ×10-4 M Chir 99021 (Stemgent) 10 mM 0.2 ul/ml 2 uM Activin A 100 ug/ml 1 ul/ml 100 ng/ml T1 and T2 MEDIA Basic Media RPMI Ingredient Stock Volume Final Glutamine 100x 10 ul/ml 1x MTG 13 ul/ml 3 ul/ml 4.5 ×10-4 M Ascorbic Acid 5 mg/ml 10 ul/ml 50 ug/ml BMP4 10 ug/ml 0.025 ul/ml 0.25 ng/ml bFGF 10 ug/ml 0.5 ul/ml 5 ng/ml Activin A 100 ug/ml 1 ul/ml 100 ng/ml VEGF 25 ug/ml 0.4 ul/ml 10 ng/ml 13 ul/ml 3 ul/ml 4.5 ×10-4 M Ascorbic Acid 5 mg/ml 10 ul/ml 50 ug/ml BMP4 10 ug/ml 0.025 ul/ml 0.25 ng/ml bFGF 10 ug/ml 0.5 ul/ml 5 ng/ml Activin A 100 ug/ml 1 ul/ml 100 ng/ml VEGF 25 ug/ml 0.4 ul/ml 10 ng/ml 10 ul/ml MTG 13 ul/ml 3 ul/ml Ascorbic Acid 5 mg/ml 10 ul/ml BMP4 10 ug/ml 1 ul/ml bFGF 10 ug/ml 0.5 ul/ml Activin A 100 ug/ml 0.5 ul/ml VEGF 10 ug/ml 1 ul/ml Final 1x 4.5 × 10-4 M 50 ug/ml 10 ng/ml 5 ng/ml 50 ng/ml 10 ng/ml DE T7-T12 MEDIA Basic Media SFD Ingredient Stock Volume Final Glutamine 100x 10 ul/ml 1x MTG 13 ul/ml 3 ul/ml 4.5 × 10-4 M Ascorbic Acid 5 mg/ml 10 ul/ml 50 ug/ml BMP4 100 ug/ml 0.5 ul/ml 50 ng/ml bFGF 100 ug/ml 0.1 ul/ml 10 ng/ml VEGF 25 ug/ml 0.4 ul/ml 10 ng/ml EGF 50 ug/ml 0.2 ul/ml 10 ng/ml TGFα 50 ug/ml 0.4 ul/ml 20 ng/ml HGF 100 ug/ml 1 ul/ml 100 ng/ml DEX 50 uM 2 ul/ml 100 nM 13 ul/ml 3 ul/ml 4.5 × 10-4 M Ascorbic Acid 5 mg/ml 10 ul/ml 50 ug/ml bFGF 100 ug/ml 0.1 ul/ml 10 ng/ml VEGF 25 ug/ml 0.4 ul/ml 10 ng/ml EGF 50 ug/ml 0.2 ul/ml 10 ng/ml HGF 100 ug/ml 1 ul/ml 100 ng/ml OSM 100 ug/ml 0.2 ul/ml 20 ng/ml DEX 50 uM 4 ul/ml 200 nM VK 10 mg/ml 0.6 ul/ml 6 ug/ml DMSO dry 10 ul/ml 1% gSI 1 mM 1.5 ul/ml 1.5 uM Liver T19-T25 Basic Media SFD Ingredient Stock Volume Final MTG 13 ul/ml 3 ul/ml 4.5 ×10-4 M Ascorbic Acid 5 mg/ml 10 ul/ml 50 ug/ml HGF 100 ug/ml 1 ul/ml 100 ng/ml OSM 100 ug/ml 0.2 ul/ml 20 ng/ml DEX 50 uM 2 ul/ml 100 nM VK 10 mg/ml 0.6 ul/ml 6 ug/ml
